Published in Scand J Infect Dis on January 01, 1992
Toxoplasma gondii: from animals to humans. Int J Parasitol (2000) 10.45
Antenatal screening for Toxoplasma gondii infection at a tertiary care hospital in Riyadh, Saudi Arabia. Ann Saudi Med (2011) 1.56
Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol (1998) 1.10
Development of specific immunoglobulins G, M, and A following primary Toxoplasma gondii infection in pregnant women. J Clin Microbiol (1998) 1.08
Modified latex agglutination test for antibodies to Toxoplasma gondii in eluates from Guthrie cards. J Clin Pathol (1992) 0.98
Serological prevalence of Toxoplasma gondii antibodies in pregnant women from Southern Brazil. Parasitol Res (2010) 0.97
Detection of Toxoplasma gondii tachyzoites and bradyzoites in blood, urine, and brains of infected mice. Clin Diagn Lab Immunol (1996) 0.96
Prevalence of antibodies to Toxoplasma gondii in the female population of the County of Split Dalmatia, Croatia. Eur J Epidemiol (2000) 0.84
Gestational and neonatal toxoplasmosis: regional seroprevalence in the United Arab Emirates. Eur J Epidemiol (1997) 0.82
Radiological signs in newborns exposed to primary Toxoplasma infection in utero. Pediatr Radiol (1997) 0.80
Contact with pigs and cats associated with high prevalence of Toxoplasma antibodies among farmers. Br J Ind Med (1992) 0.79
Seroprevalence of Toxoplasma gondii infection among pregnant women in Cameroon. J Public Health Africa (2011) 0.75
Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study. BMC Pregnancy Childbirth (2016) 0.75
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA (2001) 5.99
Mother's weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study. BMJ (1997) 3.63
Normal intelligence in children with prenatal exposure to carbamazepine. Neurology (2004) 3.58
Increased nuchal translucency as a marker for fetal chromosomal defects. N Engl J Med (1997) 3.01
Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet (1997) 2.86
False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol (1997) 2.84
Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1) Science (1996) 2.73
External fibronectin of cultured human fibroblasts is predominantly a matrix protein. J Cell Biol (1978) 2.70
Depression and anxiety in early pregnancy and risk for preeclampsia. Obstet Gynecol (2000) 2.56
Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet (1994) 2.50
Toxoplasmosis needs evaluation. An overview and proposals. Am J Dis Child (1989) 2.49
Localization of the EPM1 gene for progressive myoclonus epilepsy on chromosome 21: linkage disequilibrium allows high resolution mapping. Hum Mol Genet (1993) 2.46
Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J Infect Dis (1993) 2.45
Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia (2000) 2.27
Structure of the pericellular matrix: association of heparan and chondroitin sulfates with fibronectin-procollagen fibers. Cell (1982) 2.20
Isolation of the pericellular matrix of human fibroblast cultures. J Cell Biol (1979) 2.19
Fetal head growth retardation associated with maternal antiepileptic drugs. Lancet (1981) 2.15
A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes (1995) 2.08
Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod (2001) 1.98
Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. J Cell Biol (1988) 1.97
Humoral immunity against Francisella tularensis after natural infection. J Clin Microbiol (1985) 1.94
Epidemiological study of nephropathia epidemica in Finland 1989-96. Scand J Infect Dis (1999) 1.93
Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol (1999) 1.92
Uukuniemi virus maturation: accumulation of virus particles and viral antigens in the Golgi complex. Mol Cell Biol (1982) 1.80
Chlamydia trachomatis seropositivity during pregnancy is associated with perinatal complications. Clin Infect Dis (1995) 1.79
Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem (1996) 1.79
Risk of minor and major fetal malformations in diabetics with high haemoglobin A1c values in early pregnancy. Br Med J (Clin Res Ed) (1984) 1.77
Microvillus-specific Mr 75,000 plasma membrane protein of human choriocarcinoma cells. J Histochem Cytochem (1987) 1.71
Early androgenetic alopecia as a marker of insulin resistance. Lancet (2000) 1.71
Viral encephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol (2005) 1.69
Chlamydia trachomatis seroprevalence atlas of Finland 1983-2003. Sex Transm Infect (2007) 1.69
Maternal vitamin levels during pregnancies producing infants with neural tube defects. J Pediatr (1992) 1.66
Cerebrospinal fluid alterations in herpes simplex virus encephalitis. Rev Infect Dis (1984) 1.64
Disseminated toxoplasmosis after liver transplantation: case report and review. Clin Infect Dis (1998) 1.64
Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis (1994) 1.59
Cost-benefit analysis of screening for toxoplasmosis during pregnancy. Scand J Infect Dis (1995) 1.56
Postfixation detergent treatment for immunofluorescence suppresses localization of some integral membrane proteins. J Histochem Cytochem (1985) 1.55
Prognostic factors in childhood acute encephalitis. Pediatr Infect Dis J (1991) 1.53
Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study. Diabetologia (2005) 1.52
Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor. J Pediatr (1994) 1.52
Real-time PCR for detection and quantitation of hepatitis B virus DNA. J Med Virol (2001) 1.52
Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study. Diabetes (2000) 1.50
Human spumaretrovirus in the etiology of sudden hearing loss. Acta Otolaryngol (1993) 1.49
Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol (1998) 1.48
Correlation of HbA1C, glycated serum proteins and albumin, and fructosamine with the 24-h glucose profile of insulin-dependent pregnant diabetics. Clin Chem (1989) 1.45
Predicting delivery date by ultrasound and last menstrual period in early gestation. Obstet Gynecol (2001) 1.45
Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT. Bone Marrow Transplant (2013) 1.41
Familial herpes encephalitis. Lancet (1995) 1.40
Stability over time of serum antibody levels to human papillomavirus type 16. J Infect Dis (1998) 1.39
From local to global in quasiconformal structures. Proc Natl Acad Sci U S A (1996) 1.39
Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J Infect Dis (1995) 1.37
Cell-mediated and humoral immunity induced by a live Francisella tularensis vaccine. Infect Immun (1982) 1.37
Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. J Infect Dis (1996) 1.36
Agglutination and ELISA methods in the diagnosis of tularemia in different clinical forms and severities of the disease. J Infect Dis (1986) 1.33
Progressive myoclonus epilepsy. A clinical and histopathological study. Acta Neurol Scand (1974) 1.32
Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J Infect Dis (1995) 1.31
Objectively measured tobacco exposure during pregnancy: neonatal effects and relation to maternal smoking. Br J Obstet Gynaecol (1993) 1.30
Serum HCG 12 days after embryo transfer in predicting pregnancy outcome. Hum Reprod (2002) 1.29
Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst (1997) 1.29
Cell-mediated immunity against Francisella tularensis after natural infection. Scand J Infect Dis (1980) 1.28
Localization of a gene for progressive myoclonus epilepsy to chromosome 21q22. Proc Natl Acad Sci U S A (1991) 1.27
Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis (2001) 1.26
Fetal nuchal translucency and normal chromosomes: a long-term follow-up study. Ultrasound Obstet Gynecol (2001) 1.26
Intracellular vesicles involved in the transport of Semliki Forest virus membrane proteins to the cell surface. EMBO J (1983) 1.26
Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy. Sex Transm Infect (1999) 1.24
Progressive myoclonus epilepsy: genetic and nosological aspects with special reference to 107 Finnish patients. Clin Genet (1979) 1.24
Asthma and pregnancy: a prospective study of 198 pregnancies. Thorax (1988) 1.24
Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica. Clin Nephrol (1994) 1.21
Clinical appearance and outcome in mumps encephalitis in children. Acta Paediatr Scand (1983) 1.20
Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer (2002) 1.20
Sonographic measurement of uterine cervix at 18-22 weeks' gestation and the risk of preterm delivery. Obstet Gynecol (1998) 1.19
Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet (1997) 1.18
A new method with general diagnostic utility for the calculation of immunoglobulin G avidity. Clin Diagn Lab Immunol (1999) 1.17
Sleep-related disordered breathing during pregnancy in obese women. Chest (2001) 1.17
Haemoglobin AIc predicts the perinatal outcome in insulin-dependent diabetic pregnancies. Br J Obstet Gynaecol (1981) 1.17
Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with type I diabetes mellitus. Diabetologia (2000) 1.16
Decreasing prevalence of helicobacter antibodies in Finland, with reference to the decreasing incidence of gastric cancer. Epidemiol Infect (2001) 1.16
Human fetal insulin metabolismearly in gestation. Response to acutelevation of the fetal glucose concentration and placental tranfer of human insulin-I-131. Diabetes (1969) 1.15
Inflammatory markers and retinopathy in pregnancies complicated with type I diabetes. Eye (Lond) (2005) 1.15
Outcome of children after maternal primary Toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. The Study Group. Pediatr Infect Dis J (1995) 1.15